Drawing for CLB-TRANSFECTION

USPTO serial 79074723

CLB-TRANSFECTION

Reviewed by CopyMark Law Group

Reg. 3790467Status 404
Filing date
Status date
Registration date
May 18, 2010
Examiner
ALTREE, NICHOLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLB-TRANSFECTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Perry

David M. Perry Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103-6998

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biochemical preparations used in industry and science for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; buffer and standard solutions for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins, for scientific and research use; chemical preparations for scientific purposes in the nature of laboratory chemicals for cell culture, namely, aqueous solutions containing nutrients for cultivating living cells; biological agents, namely, buffer and standard solutions containing living cells, proteins, peptides and/or nucleic acid molecules for laboratory use other than for medical and veterinary purposes; diagnostic preparations other than for medical and veterinary purposes; biological reagents for laboratories, namely, peptides, proteins, nucleic acids and complexes made of peptides, proteins and/or nucleic acids, for scientific and research use, namely, for detecting gene expression and localizing proteins as well as for integrating foreign nucleic acids into the genome of living cells and transient production of proteins for laboratory use; chemicals for use in science to transfer foreign genetic material into another cell, namely, nucleic acid molecules in the nature of expression and control vectors for laboratory use; biochemical reagents for non-medical purposes commonly known as transfection reagents for transient production of proteins for laboratory useSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary use; living cells for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; cultures of microorganisms, namely, bacterial and viral preparations for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; proteins, peptides, nucleic acid sequences and biochemical reagents of these molecules for medical and veterinary use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancerSECTION 71 - CANCELLED—
009Scientific apparatus and instruments, namely, electrical equipment in the nature of electrical field generators and capacitor impulse generators for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; apparatus and instruments for electroporation, namely, electroporators and their peripheral equipment; apparatus and instruments for conducting, switching, converting, storing, controlling and monitoring of electricity, namely, electrical capacitors, electrical conductors and contacts, power semiconductors, transistors, relays, transformers, and electric parameter monitor modules; laboratory equipment and supplies, namely, devices, containers and reaction vessels for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; test tubes; electrodes made of metal and conductive polymers; cuvettes, namely, test tubes having electrodes made of metal and conductive polymers for biochemical purposes; multi-well plates having electrodes made of metal and conductive polymers for biochemical purposes; data processors and computers; computer peripherals; computer programs and software recorded on data media designed for use in controlling of scientific apparatus and instruments for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteinsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 27, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 27, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 29, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 28, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 28, 2017INPCINVALIDATION PROCESSED—
Aug 23, 2017INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 23, 2016C71TCANCELLED SECTION 71—
May 18, 2015REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 9, 2013CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 29, 2012CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 3, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 11, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 5, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 18, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 2, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 10, 2010NPUBNOTICE OF PUBLICATION—
Jan 28, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 28, 2010ALIEASSIGNED TO LIE—
Jan 5, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 3, 2009DOCKASSIGNED TO EXAMINER—
Dec 2, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 28, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 27, 2009LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Nov 26, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance